These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8357031)

  • 21. Attitudes regarding utilization of artificial insemination by donor in Huntington disease.
    McCormack MK; Leiblum S; Lazzarini A
    Am J Med Genet; 1983 Jan; 14(1):5-13. PubMed ID: 6219582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of German persons at risk for Huntington's disease toward predictive and prenatal testing.
    Kreuz FR
    Genet Couns; 1996; 7(4):303-11. PubMed ID: 8985735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
    Bloch M; Fahy M; Fox S; Hayden MR
    Am J Med Genet; 1989 Feb; 32(2):217-24. PubMed ID: 2522735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presymptomatic testing for Huntington chorea: ethical and legal issues.
    Lamport AT
    Am J Med Genet; 1987 Feb; 26(2):307-14. PubMed ID: 2949614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reluctance to undergo predictive testing: the case of Huntington disease.
    Quaid KA; Morris M
    Am J Med Genet; 1993 Jan; 45(1):41-5. PubMed ID: 8418657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes regarding molecular diagnosis in Mexican families at risk of inheriting Huntington's disease.
    Garcia de la Cadena C; Alonso ME; Ochoa A; Martinez C
    Arch Med Res; 1997; 28(4):513-6. PubMed ID: 9428575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test.
    Timman R; Roos R; Maat-Kievit A; Tibben A
    Health Psychol; 2004 Mar; 23(2):189-97. PubMed ID: 15008664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.
    Lam RW; Bloch M; Jones BD; Marcus AM; Fox S; Amman W; Hayden MR
    J Clin Psychiatry; 1988 Nov; 49(11):444-7. PubMed ID: 2972696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
    Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cloostermans T; Cassiman JJ; Demyttenaere K; Dom R; Fryns JP; Van den Berghe H
    Eur J Hum Genet; 1997; 5(6):351-63. PubMed ID: 9450179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
    van der Steenstraten IM; Tibben A; Roos RA; van de Kamp JJ; Niermeijer MF
    Am J Hum Genet; 1994 Oct; 55(4):618-25. PubMed ID: 7942839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of fertility and fitness in Huntington disease in New England.
    Mastromauro CA; Meissen GJ; Cupples LA; Kiely DK; Berkman B; Myers RH
    Am J Med Genet; 1989 Jun; 33(2):248-54. PubMed ID: 2527461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes of Dutch general practitioners towards presymptomatic DNA-testing for Huntington disease.
    Thomassen R; Tibben A; Niermeijer MF; van der Does E; van de Kamp JJ; Verhage F
    Clin Genet; 1993 Feb; 43(2):63-8. PubMed ID: 8448902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes of persons at risk and their partners toward predictive testing.
    Jacopini GA; D'Amico R; Frontali M; Vivona G
    Birth Defects Orig Artic Ser; 1992; 28(1):113-7. PubMed ID: 1340220
    [No Abstract]   [Full Text] [Related]  

  • 36. Presymptomatic DNA-testing for Huntington disease in The Netherlands.
    Tibben A; Vegter-vd Vlis M; Skraastad MI; Leeuwen-Cornelisse IS; Frets PG; vd Kamp JJ; Niermeijer MF; von Ommen GJ; Roos RA; Rooijmans HG
    Birth Defects Orig Artic Ser; 1992; 28(1):127-31. PubMed ID: 1340222
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive testing for Huntington disease: social characteristics and knowledge of applicants, attitudes to the test procedure and decisions made after testing.
    Holloway S; Mennie M; Crosbie A; Smith B; Raeburn S; Dinwoodie D; Wright A; May H; Calder K; Barron L
    Clin Genet; 1994 Aug; 46(2):175-80. PubMed ID: 7820927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in attitudes toward presymptomatic testing in Huntington disease.
    Mastromauro C; Myers RH; Berkman B
    Am J Med Genet; 1986 Jun; 24(2):369-71. PubMed ID: 3013007
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of laboratory or clerical error on presymptomatic risk calculations for Huntington disease: a simulation study.
    King TM; Brandt J; Meyers DA
    Am J Med Genet; 1993 Apr; 46(2):154-8. PubMed ID: 8484402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.